Can glandular lesions be diagnosed pap smear cytology?

Diagnostic Cytopathology

Volumn 23, Issue 2, 2000, Pages 127-133

  Gordon, H Yu ^a   Lawton, Thomas J ^a   Pasha, Theresa L ^a   Reynolds, Carol ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Accuracy; Cancer; Error; Sensitivity

Indexed keywords

ADENOCARCINOMA; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DYSPLASIA; ENDOMETRIUM CYTOLOGY; FEMALE; HUMAN; PAPANICOLAOU TEST; PRIORITY JOURNAL; REVIEW; TUMOR CLASSIFICATION; VAGINA SMEAR;

ADENOCARCINOMA; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMAN; SENSITIVITY AND SPECIFICITY; TERMINOLOGY; VAGINAL SMEARS;

EID: 0033853729     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0339(200008)23:2<127::AID-DC13>3.0.CO;2-I     Document Type: Review

References (108)

1. The Bethesda system for reporting cervical/vaginal diagnoses
2. The Bethesda system for reporting cervical/vaginal diagnoses
3. Current issues: The 1991 The Bethesda system for reporting cervical/vaginal diagnoses
4. Atypical glandular cells of undetermined significance. Cytologic criteria to separate clinically significant from benign lesions
5. Adenocarcinoma of the uterine cervix: Cytologic evidence of a long preclinical evolution
6. Papanicolaou smear sensitivity for adenocarcinoma in situ of the cervix. A study of 34 cases
7. Analysis of cervical smears obtained within three years of the diagnosis of invasive cervical cancer
8. False-negative results in cervical cytologic studies
9. 'Litigation cells' in the Papanicolaou smear: Extramuralreview of smears by 'experts'
10. Efficacy of screening for cervical squamous and adenocarcinoma: The Dutch experience
11. False-negative Papanicolaou smears from women with cancerous and precancerous lesions of the uterine cervix
12. Percentages of cervical cytologic diagnoses as a quality assurance method
13. A retrospective review of adenocarcinoma-in-situ and glandular atypia of the uterine cervix
14. Precancerous lesions of the cervix
15. Adenocarcinoma in situ of the uterine cervix: A clinico-pathologic study of 36 cases
16. Noninvasive precursor lesions of adenocarcinoma and mixed adenosquamous carcinoma of the cervix uteri
17. A prospective study of conization of the cervix in the management of cervical intraepithelial glandular neoplasia (CIGN) - A preliminary report
18. Adenocarcinoma in situ of the cervix. Clinico-pathologic observations of 11 cases
19. Adenocarcinoma in situ of the uterine cervix
20. Endocervical glandular atypia: Does a preneoplastic lesion of adenocarcinoma in situ exist?
21. Cervical adenocarcinoma in situ
22. Adenocarcinoma of the cervix: Histopathologic and clinical features
23. Cytologic features of well-differentiated villoglandular adenocarcinoma of the cervix
24. Endocervical adenocarcinoma in situ: An analysis of cellular features
25. Endocervical adenocarcinoma in situ of tubal type and its relation to atypical tubal metaplasia
26. AGUS in cervical endometriosis
27. Utility of the cervical cytologic smear in assessing endocervical involvement by endometrial carcinoma
28. The role of cytology in the diagnosis and follow-up of patients with cervical adenocarcinoma
29. Evaluation of the atypical cytologic smear. Validity of the 1991 Bethesda system
30. Comparative cytologic features of adenocarcinoma in situ of the uterine cervix
31. Atypical glandular cells in cervical smears from women who have undergone cone biopsy: A potential diagnostic pitfall
32. Atypical endocervical glandular cells: Accuracy of cytologic diagnosis
33. Microinvasive adenocarcinoma of the cervix: A cytohistopathologic study of 40 cases
34. Adenocarcinoma in situ of the uterine cervix
35. In-situ and microinvasive adenocarcinoma of the uterine cervix. A clinical, cytologic and histologic study of 14 cases
36. Cytologic features of villoglandular adenocarcinoma of the uterine cervix: Comparison with typical endocervical adenocarcinoma with a villoglandular component and papillary serous carcinoma
37. Cervicovaginal cytology in uterine adenocarcinoma and adenosquamous carcinoma: Comparison of cytologic and histologic findings
38. Endocerical glandular atypia and adenocarcinoma: A correlation of cytology and histology
39. The histologic diagnosis of adenocarcinoma in situ and related lesions of the cervix uteri. Adenocarcinoma in situ
40. Evaluation of the Thin-Prep Pap test in clinical practice. A seven-month, 16,314-case experience in northern Vermont
41. Use of thin-layer preparations for gynecologic smears with emphasis on the cytomorphology of high-grade intraepithelial lesions and carcinomas
42. Accuracy comparison between PAPNET diagnoses and conventional diagnoses in an Italian cervical cytology laboratory
43. Endocervical glandular neoplasia and its mimics in ThinPrep Pap tests. A descriptive study
44. Analysis of atypical squamous (glandular) cells of undetermined significance smears by neural network-directed review
45. Utility of residual AutoCyte cervical cytology samples for image analysis
46. Comparison of ThinPrep and Pap smear, in relation to prediction of adenocarcinoma in situ
47. ThinPrep Pap test. Accuracy for glandular disease
48. Recent negative cytology prior to histologically confirmed carcinoma in situ of the cervix
49. Clinical presentation and management of stage I cervical adenocarcinoma: A 25 year experience
50. Adenocarcinoma of the uterine cervix
51. Early stage adenocarcinoma of the uterine cervix. Histopathologic analysis with consideration of histogenesis
52. Prognostic factors in adenocarcinoma of the uterine cervix
53. Carcinoma and other tumors of the cervix
54. Endometrial carcinoma
55. Detection of endometrial carcinoma and hyperplasia in asymptomatic women
56. Atypical glandular cells of undetermined significance, favor endometrial origin: Diagnostic criteria to separate benign from malignant lesions
57. Prognostic significance of malignant cervical cytology in patients with endometrial cancer
58. The prognostic significance of cervico-vaginal cytology in endometrial cancer
59. Influence of histologic and cytologic grade and the clinical and the postsurgical stage on the rate of endometrial adenocarcinoma detection by cervical cytology
60. Accuracy and survival benefit of cytological prediction of endometrial carcinoma on routine cervical smears
61. Factors determining the degree of exfoliation and their diagnostic implications in endometrial adenocarcinoma
62. Endometrial carcinoma: The relevance of cervical cytology
63. The effect of cervical disease history on outcomes of women who have a Pap diagnosis of atypical glandular cells of undetermined significance
64. Abnormal endocervical cells: Really abnormal? Really endocervical?
65. Atypical glandular cells of undetermined significance: A five-year retrospective histopathologic study
66. Glandular lesions of the cervix: Validity of cytologic criteria used to differentiate reactive changes, glandular intraepithelial lesions and adenocarcinoma
67. Endocervical glandular atypia in Papanicolaou smears
68. Endocervical glandular atypia and adenocarcinoma: A correlation of cytology and histology
69. Atypical cervical cytology. Colposcopic follow-up using the Bethesda system
70. Neoplasia associated with atypical glandular cells of undetermined significance on cervical cytology
71. Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening
72. Clinical evaluation of atypical glandular cells of undetermined significance on cervical cytology
73. Biopsy findings in five hundred thirty-one patients with atypical glandular cells of uncertain significance as defined by the Bethesda system
74. A study of 10,296 pediatric and adolescent Papanicolaou smear diagnoses in northern New England
75. The significance of atypical glandular cells on Papanicolaou smears: An 8-year follow-up study
76. Follow-up of atypical glandular cells in cervical-endocervical smears
77. Atypical glandular cells of undetermined significance (AGUS): Cytopathologic features, histopathologic results, and human papillomavirus DNA detection
78. Importance of atypical glandular cells of uncertain significance in cervical cytologic smears
79. Atypical glandular cells of undetermined significance in cervical cytologic findings
80. The Bethesda system and evaluation of abnormal Pap smears
81. Evaluation of atypical and low-grade cervical cytology in private practice
82. Update on the Papanicolaou smear: New issues for the 1990s
83. Atypical glandular cells of undetermined significance on cervical smears. A study with cytohistologic correlation
84. Atypical glandular cells of undetermined significance and adenocarcinoma in situ: Summoning colposcopic expertise?
85. Endocervical glandular atypia in Papanicolaou smears
86. Long term outcomes and relative risk of women who have a diagnosis of atypical squamous cells of undetermined significance
87. Tubal metaplasia: A frequent potential pitfall in the cytologic diagnosis of endocervical glandular dysplasia on cervical smears
88. The spectrum and significance of atypical glandular cells of undetermined significance (AGUS) on Papanicolaou smears
89. The effects of endocervical canal topography, tubal metaplasia, and high canal sampling on the cytologic presentation of nonneo-plastic endocervical cells
90. Endocervical columnar cell intraepithelial neoplasia I: Discriminating cytomorphologic criteria
91. Endocervical columnar cell intraepithelial neoplasia, II: Grades of expression of cytomorphologic criteria
92. Atypical glandular cells of undetermined significance. Diagnostic accuracy and interobserver variability using select cytologic criteria
93. Cytologic features of neoplastic lesions in endocervical glands
94. The 'inconclusive - Possible high grade epithelial abnormality' category in Papanicolaou smear reporting
95. Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses
96. Interobserver variability of a Papanicolaou smear diagnosis of atypical glandular cells of undetermined significance
97. Significance of endometrial cells in the detection of endometrial adenocarcinoma
98. Significance of atypical endometrial cells detected by cervical cytology
99. Classification of endometrial cells on cervical cytology
100. ASCCP practice guidelines: Management of glandular abnormalities in the cervical smear
101. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix
102. The minimally abnormal Papanicolaou smear
103. Comparing two modalities of management of women with cytologic evidence of squamous or glandular atypia: Early repeat cytology or colposcopy
104. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears
105. Adenocarcinoma in situ of the cervix: Management and outcome
106. Delay times to definitive diagnosis after an abnormal Pap smear
107. The status and distance of cone biopsy margins as a predictor of excision adequacy for endocervical adenocarcinoma in situ